Orlistat
Study Exploring the Supportive Effect of Acarbose in Weight Management
Empros Pharma AB · Phase 2 · Status n/r · Enrollment 320
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| EMP16-120/40 | n/r | n/r | n/r | n/r |
| MR orlistat | n/r | n/r | n/r | n/r |
| Conventional orlistat | n/r | n/r | n/r | n/r |
| EMP16-60/20 | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r |
Not shown
- EMP16-120/40: endpoint not reported
- MR orlistat: endpoint not reported
- Conventional orlistat: endpoint not reported
- EMP16-60/20: endpoint not reported
- Placebo: endpoint not reported